MSD's plan to reduce its headcount by around 6,000, first revealed a couple of weeks ago, looks like it will start at its headquarters in Rahway, New Jersey. Confirmation of that has come in the form ...
Pharmaceutical giant MSD is slashing $3bn (€2.59bn) from its annual spending as part of global job cut but said it will not be closing any of its Irish sites. Pharmaceutical giant MSD is slashing $3bn ...
The safety profile of MSD’s Keytruda during the trial aligned with previous studies. Credit: Copyright © 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates ...
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
Medicines giant MSD has officially opened expanded facilities at its Carlow vaccines plant as well as a new biologics unit in Dunboyne, Co Meath. The company, known in the United States as Merck, said ...
C-SPAN is testing some improvements to our website and we'd like to ask for your help. Please click here to try out our new video viewing page (you can switch back at any time). User-Created Clip ...
Merck & Co (MSD) has announced that it is discontinuing two Phase III Keytruda (pembrolizumab) clinical trials. The KEYNOTE-867 (NCT03924869) trial was evaluating Keytruda plus stereotactic body ...
Pharmaceutical giant MSD Ireland has opened a new manufacturing facility in Swords, Co Dublin, to increase supply of its blockbuster cancer drug Keytruda. The facility is part of its MSD Biotech arm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback